Drugmaker Shire rejects 27 bn pound bid from US giant AbbVie
Shire Pharmaceuticals rejected Friday a £27-billion informal bid from US giant AbbVie, arguing that it "fundamentally" undervalued the group, in the latest blockbuster deal to hit the global drugs sector.
Jun 20, 2014, 15:30 PM IST